Literature DB >> 17254755

Preparation and characterization of N-succinyl-N'-octyl chitosan micelles as doxorubicin carriers for effective anti-tumor activity.

Xu Xiangyang1, Li Ling, Zhou Jianping, Lu Shiyue, Yang Jie, Yin Xiaojin, Ren Jinsheng.   

Abstract

N-Succinyl-N'-octyl chitosan (SOC) was prepared and characterized by elemental analysis, FTIR, (1)H NMR, WAXD and TG. An anticancer drug, doxorubicin (DOX), was incorporated into polymeric micelles forming by SOC in aqueous solutions. Critical micelle concentrations (CMC) of SOC were determined by fluorescence spectroscopy. The DOX-loaded SOC micelles were characterized by measurement of size and drug loading. The loading content of DOX increased with increasing drug-to-carrier ratio, and the more amount of the octyl chain, the higher the drug loading content. The average size, which was affected by the amount of octyl chain and drug loading content, was in the range of 100-200 nm. The polymeric micelles containing doxorubicin in the core region exhibited a sustained release and more cytotoxic activity against HepG2, A549, BGC and K562 than doxorubicin alone, this can be attributed to an endocytosis mechanism rather than passive diffusion.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17254755     DOI: 10.1016/j.colsurfb.2006.12.006

Source DB:  PubMed          Journal:  Colloids Surf B Biointerfaces        ISSN: 0927-7765            Impact factor:   5.268


  15 in total

1.  Synthesis and characterization of poly(ε-caprolactone)-block-poly[N-(2-hydroxypropyl)methacrylamide] micelles for drug delivery.

Authors:  Stefan G Krimmer; Huaizhong Pan; Jihua Liu; Jiyuan Yang; Jindřich Kopeček
Journal:  Macromol Biosci       Date:  2011-05-12       Impact factor: 4.979

2.  Controlled Drug Release from Pharmaceutical Nanocarriers.

Authors:  Jinhyun Hannah Lee; Yoon Yeo
Journal:  Chem Eng Sci       Date:  2015-03-24       Impact factor: 4.311

Review 3.  Nanomicellar formulations for sustained drug delivery: strategies and underlying principles.

Authors:  Ruchit Trivedi; Uday B Kompella
Journal:  Nanomedicine (Lond)       Date:  2010-04       Impact factor: 5.307

4.  Synthesis and characterization of arginine-glycine-aspartic peptides conjugated poly(lactic acid-co-L-lysine) diblock copolymer.

Authors:  Hui Yu; Xiaojuan Guo; Xueliang Qi; Peifeng Liu; Xinyuan Shen; Yourong Duan
Journal:  J Mater Sci Mater Med       Date:  2007-08-20       Impact factor: 3.896

5.  Zwitterionic chitosan-polyamidoamine dendrimer complex nanoparticles as a pH-sensitive drug carrier.

Authors:  Karen C Liu; Yoon Yeo
Journal:  Mol Pharm       Date:  2013-04-03       Impact factor: 4.939

6.  Chondroitin/doxorubicin nanoparticulate polyelectrolyte complex for targeted delivery to HepG2 cells.

Authors:  Jaleh Varshosaz; Hojjat Sadeghi Aliabadi; Fereshte Asheghali
Journal:  IET Nanobiotechnol       Date:  2017-03       Impact factor: 1.847

7.  In vitro investigation of self-assembled nanoparticles based on hyaluronic acid-deoxycholic acid conjugates for controlled release doxorubicin: effect of degree of substitution of deoxycholic acid.

Authors:  Wen-Hao Wei; Xue-Meng Dong; Chen-Guang Liu
Journal:  Int J Mol Sci       Date:  2015-03-31       Impact factor: 5.923

8.  Tumor-targeted polymeric nanostructured lipid carriers with precise ratiometric control over dual-drug loading for combination therapy in non-small-cell lung cancer.

Authors:  Yan Liang; Baocheng Tian; Jing Zhang; Keke Li; Lele Wang; Jingtian Han; Zimei Wu
Journal:  Int J Nanomedicine       Date:  2017-03-02

9.  Simulation of doxorubicin delivery via glucosamine(ethylene glycol) carrier.

Authors:  Thongjun Pirawattana; Thongchai Srinophakun
Journal:  Int J Mol Sci       Date:  2008-11-21       Impact factor: 6.208

10.  The effect of substituent, degree of acetylation and positioning of the cationic charge on the antibacterial activity of quaternary chitosan derivatives.

Authors:  Priyanka Sahariah; Vivek S Gaware; Ramona Lieder; Sigríður Jónsdóttir; Martha Á Hjálmarsdóttir; Olafur E Sigurjonsson; Már Másson
Journal:  Mar Drugs       Date:  2014-08-21       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.